marzan, if keytruda and the autologous dendritic cell vaccine (DCVax-L) work successfully together in the UCLA combo trial of recurrent GBM, there may eventually be a prominent place for a combination of DCVax and keytruda as a treatment for many types of solid operable and non operable cancers.
Market Data 
Markets 
AI
